title: Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
abstract: A decoction of stem bark of Oroxylum indicum Vent. (OI) is taken (2-3 times/day) by the tribal people of Sikkim, India to treat diabetes but scientific validation of its overall potential is lacking. Present study was aimed to assess in vitro antihyperglycemic activity of standardized OI extract using inhibition of α-glucosidase, BSA glycation and enhancement of insulin sensitivity. Antidiabetic and antioxidant modulatory effects of OI extract along with the blood biomarkers of toxic response were studied in streptozotocin (STZ) induced diabetic rats. In vitro analysis showed strong antioxidant capacity of OI -and potential to inhibit BSA glycation and α-glucosidase activity which was comparable to standard counterparts. Extract also improved insulin sensitivity in mature 3T3-L1 adipocytes. In vivo effects of OI extract (oral 250 mg/kg b.wt.) on STZ induced type II diabetic rats normalized the antioxidant status (p≤0.01). Analysis of blood biomarkers of toxic response indicated its safety. Lowering of total cholesterol and HDL levels (p≤0.05) and restoration of glycated Hb (p≤0.01) were also found in OI treated diabetic rats. HOMA-IR, QUICKI analysis along with area under the curve analysis showed the capacity of OI extract to enhance the insulin sensitivity significantly (p≤0.01) which was confirmed by increased GLUT-4 translocation in skeletal muscles.
authors.affiliation: Herbal Research Section, CSIR-Indian Institute of Toxicology Research, Post Box No. 80, Mahatma Gandhi Marg, Lucknow 226001, UP, India.
authors.forename: Jyotsna
authors.initials: J
authors.lastname: Singh
authors.forename: Poonam
authors.initials: P
authors.lastname: Kakkar
mesh_terms: D041721:3T3-L1 Cells / Q000187:drug effects; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D029402:Bignoniaceae / Q000737:chemistry; D001692:Biological Transport / Q000187:drug effects; D001786:Blood Glucose / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007194:India; D007333:Insulin Resistance; D008099:Liver / Q000187:drug effects / Q000502:physiology; D008297:Male; D051379:Mice; D010936:Plant Extracts / Q000032:analysis / Q000737:chemistry / Q000494:pharmacology*; D010946:Plants, Medicinal; D051381:Rats; D017208:Rats, Wistar; D012710:Serum Albumin, Bovine / Q000378:metabolism; D013311:Streptozocin; D000520:alpha-Glucosidases / Q000378:metabolism
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010936:Plant Extracts; D012710:Serum Albumin, Bovine; D013311:Streptozocin; D000520:alpha-Glucosidases; D005947:Glucose
keywords: (4-NPGP); (ABTS); (ADA); (AGE); (ALT); (ANOVA); (AST); (AUC); (Akt/PKB); (BSA); (BUN); (CPCSEA); (DM); (DMEM); (DNPH); (DTNB); (FBG); (FBS); (FITC); (FRAP); (GLUT-4); (GSH); (HCT); (HDL); (HOMA-IR); (HRP); (Hb); (HbA1c); (IR); (LDL); (MCV); (MDA); (NA); (OGTT); (OI); (PBS); (PC); (PI3K); (PVDF); (QUICKI); (RBC); (ROS); (RP-HPLC); (SDS–PAGE); (STZ); (TBA); (TC); (TEAC); (TG); (TPTZ); (WBC); (WHO); 2,2′-azinobis (3-ethylbenzothiazoline-6-sulphonic acid; 2,4,6-tripyridyl-s-triazine; 2,4-dinitrophenyl hydrazine; 4-nitrophenyl p-d glucopyranoside; 5,5′dithiobis-2-nitrobenzoic acid; American diabetes association; Anti diabetic activity; Antioxidant; BSA glycation; Diabetes mellitus; Dulbecco’s Modified Eagle Medium; Insulin sensitivity; Oral Glucose Tolerance Test; Oroxylum indicum; Oroxylum indicum (OI); Trolox equivalent antioxidant capacity; World Health Organization; advanced glycation end products; alanine amino transferase; analysis of variance; area under the curve; aspartate amino transferase; blood urea nitrogen; bovine serum albumin; committee for the purpose of control and supervision of experiments on animals; differentiation media; fasting blood glucose; ferric ion reducing antioxidant power; fetal bovine serum; fluorescein isothiocyanate; glucose transporter-4; glycosylated hemoglobin; heamatocrit; hemoglobin; high density lipoprotein cholesterol; homeostatic model assessment of Insulin resistance; horse-radish peroxidase; insulin receptor; low density lipoprotein cholesterol; malondialdehyde; mean corpuscular volume; nicotinamide; phosphate buffer saline pH 7.4; phosphatidylinositol-3-kinase; polyvinylidene difluoride; protein carbonyls; protein kinase B; quantitative insulin sensitivity check index; reactive oxygen species; red blood cell counts; reduced glutathione; reverse phase high performance liquid chromatography; sodium dodecyl sulphate–polyacrylamide gel electrophoresis; streptozotocin; thiobarbituric acid; total cholesterol; total glycerides; white blood cell counts